Pharmaceutical Industry
Over the last few years, DIGIMIND has developed specialist skills in the pharmaceutical industry with several competitive intelligence systems active within the national and international projects co ordinated by the biggest laboratories (Aventis-Pasteur, Sanofi-Synthelabo, AstraZeneca etc…).
By introducing competitive intelligence procedures and service documents tailored to the requirements of their sector, laboratories have been able to improve their reactivity to developments in their competitive environment:
- Monitoring changes in competitors’ portfolios, their investments in R&D and priority advertising material
- Monitoring mergers between laboratories that could represent a threat to the company
- Monitoring the positioning of competitive drugs and the sales policy adopted by medical representatives
- Identifying and monitoring the opinion leaders and the symposia and conferences organised by the competition
- Monitoring the rumours circulating concerning drugs and identifying their sources
- Identifying competitors’ sales structures and commercial priorities
- Anticipating complaints and law-suits when a drug is launched that could impact the maximisation of sales
- Monitoring statutory developments in the health sector (non-reimbursement, generics etc…)
As the competitive stakes are now as high as the budgets for the launch of new “blockbusters”, strategic intelligence has become a vital approach for pharmaceutical laboratories. The introduction of a tailored and adaptable information system, based around DIGIMIND Evolution and with significant methodical aid, enables companies in the pharmaceutical sector to progressively develop their reactive and anticipation capacities, and provides them with a major competitive advantage over their competitors.
To find out more, see Digimind Finder, Digimind Tracker, Digimind Manager and Digimind Publisher modules, and please don’t hesitate to contact us.